FDA clears DNA test to spot cancer genes, but with warnings | KOB 4

FDA clears DNA test to spot cancer genes, but with warnings

March 06, 2018 12:21 PM

WASHINGTON (AP) — U.S. regulators have approved the first direct-to-consumer breast cancer gene test.


But the Food and Drug Administration said Tuesday it will require warnings about the limitations of the genetic information from California-based 23andMe.

The test, which analyzes DNA from saliva, can only detect three out of more than 1,000 known inherited BRCA gene mutations. It cannot determine a person's overall risk of developing cancer.

The FDA says the test is not a substitute for regular medical checkups and should not be used to make any medical decisions. Most cancers are not caused by genetic mutations, and the ones tracked by the test aren't the most common BRCA mutations.

The FDA blocked 23andMe from offering genetic health information in 2013. The company has gradually won clearance to reintroduce some testing services.


Copyright 2018 The Associated Press. All rights reserved.



Relay Media Amp



'Don't just ignore it': NM students join thousands in historic Pennsylvania Avenue march

Thousands participate in local March for Our Lives events

Gun rights supporters hold counter-protest to March for Our Lives

City's newest coffee shop has deeply personal roots

Neil Patrick Harris buys out screening for hit LGBTQ film